HIM
STIM icon

Hillsdale Investment Management’s Neuronetics STIM Stock Holding History

Hillsdale Investment Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-121,152
Closed -$353K – 651
2023
Q1 		$353K Buy
121,152
+27,000
+29% +$136K 0.03% 394
2022
Q4 		$647K Buy
+94,152
New +$444K 0.05% 267

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Hillsdale Investment Management's STIM Position: Q2 2023 in Review

Hillsdale Investment Management sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 121,152 shares — an estimated $353K sold.

Hillsdale Investment Management first reported a position in STIM in Q4 2022 and held it in 2 quarters. The position peaked at $647K in Q4 2022. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

  • Hillsdale Investment Management reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
  • Hillsdale Investment Management sold 121,152 Neuronetics shares in Q2 2023, an estimated $353K.
  • Hillsdale Investment Management first reported a position in Neuronetics in Q4 2022 and held it in 2 quarters.
  • Hillsdale Investment Management's Neuronetics position peaked at $647K in Q4 2022.
  • 69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on Hillsdale Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.